Heart monitoring as a service: iRhythm Technologies sets terms for $75 million IPO

iRhythm Technologies, which provides a device and analysis for detecting cardiac arrhythmias, announced terms for its IPO on Friday. 

The San Francisco, CA-based company plans to raise $75 million by offering 5.35 million shares at a price range of $13 to $15. Insiders intend to purchase $15 million worth of shares in the offering. At the midpoint of the proposed range, iRhythm Technologies would command a fully diluted market value of $310 million. 

Read more